• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫切除术后的乳腺癌风险:基于健康保险数据库的分析

Breast Cancer Risk After Hysterectomy: A Health Insurance Database-Based Analysis.

作者信息

Shin Yeonjin, Nahm Gyuho, Seo Jiwon, Lee Jin Li, Han Gwan Hee, Yoon Sang-Hee, Noh Ji Hyun, Kim Myounghwan, Yuk Jin-Sung

机构信息

Independent Researcher, Seoul, Korea.

Applewoman Clinic, Seoul, Korea.

出版信息

J Breast Cancer. 2025 Aug;28(4):215-227. doi: 10.4048/jbc.2025.0031. Epub 2025 Jun 16.

DOI:10.4048/jbc.2025.0031
PMID:40737069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12411075/
Abstract

PURPOSE

Despite numerous previous studies, the relationship between hysterectomies and breast cancer risk remains unclear. This study aimed to assess whether hysterectomies are significantly associated with a reduced risk of breast cancer in Korean women using data from the National Health Insurance Service database of South Korea.

METHODS

We conducted a retrospective cohort study of South Korean women aged 40-59 years who underwent hysterectomies for benign reasons or underwent a health check-up between 2003 and 2011. To minimize confounding factors, a 1:1 propensity score matching (PSM) was used to balance the groups based on key covariates. The participants were followed up until December 31, 2020. Stratified Cox proportional hazards regression analysis was performed to assess the association between hysterectomies and breast cancer risk.

RESULTS

After 1:1 PSM, 13,148 women were assigned to the hysterectomy or non-hysterectomy groups. Breast cancer occurred in 242 (1.8%) and 233 (1.8%) women in the non-hysterectomy and hysterectomy groups, respectively ( = 0.711). After adjusting for confounders, hysterectomy with or without adnexal surgery was not significantly associated with breast cancer risk (hazard ratio [HR], 0.937; 95% confidence interval [CI], 0.775-1.132 for hysterectomy with/without adnexal surgery; HR, 0.957; 95% CI, 0.779-1.176 for hysterectomy without adnexal surgery; and HR, 0.833; 95% CI, 0.513-1.353 for hysterectomy with adnexal surgery). No significant association was found when analyzing surgical methods or age at natural menopause.

CONCLUSION

Our study found no association between hysterectomies and breast cancer risk, which is consistent with previous studies that reported a null association.

摘要

目的

尽管此前有大量研究,但子宫切除术与乳腺癌风险之间的关系仍不明确。本研究旨在利用韩国国民健康保险服务数据库的数据,评估子宫切除术是否与韩国女性乳腺癌风险降低显著相关。

方法

我们对2003年至2011年间因良性原因接受子宫切除术或进行健康检查的40至59岁韩国女性进行了一项回顾性队列研究。为尽量减少混杂因素,采用1:1倾向评分匹配(PSM)根据关键协变量平衡各组。对参与者进行随访至2020年12月31日。进行分层Cox比例风险回归分析以评估子宫切除术与乳腺癌风险之间的关联。

结果

经过1:1 PSM后,13148名女性被分配到子宫切除术组或非子宫切除术组。非子宫切除术组和子宫切除术组分别有242名(1.8%)和233名(1.8%)女性发生乳腺癌(P = 0.711)。在调整混杂因素后,无论是否进行附件手术的子宫切除术与乳腺癌风险均无显著关联(风险比[HR],0.937;95%置信区间[CI],对于有/无附件手术的子宫切除术为0.775 - 1.132;对于无附件手术的子宫切除术,HR,0.957;95% CI,0.779 - 1.176;对于有附件手术的子宫切除术,HR,0.833;95% CI,0.513 - 1.353)。在分析手术方法或自然绝经年龄时未发现显著关联。

结论

我们的研究发现子宫切除术与乳腺癌风险之间无关联,这与之前报道无关联的研究一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c5/12411075/57ef8f6435dc/jbc-28-215-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c5/12411075/56dde94d425c/jbc-28-215-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c5/12411075/57ef8f6435dc/jbc-28-215-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c5/12411075/56dde94d425c/jbc-28-215-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c5/12411075/57ef8f6435dc/jbc-28-215-g002.jpg

相似文献

1
Breast Cancer Risk After Hysterectomy: A Health Insurance Database-Based Analysis.子宫切除术后的乳腺癌风险:基于健康保险数据库的分析
J Breast Cancer. 2025 Aug;28(4):215-227. doi: 10.4048/jbc.2025.0031. Epub 2025 Jun 16.
2
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.对局部晚期宫颈癌女性患者进行子宫切除术并辅以放疗或化疗或两者联合治疗。
Cochrane Database Syst Rev. 2015 Apr 7(4):CD010260. doi: 10.1002/14651858.CD010260.pub2.
3
Uterine artery embolization for symptomatic uterine fibroids.子宫动脉栓塞术治疗有症状的子宫肌瘤。
Cochrane Database Syst Rev. 2014 Dec 26;2014(12):CD005073. doi: 10.1002/14651858.CD005073.pub4.
4
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.对携带BRCA1或BRCA2基因突变的女性进行降低风险的双侧输卵管卵巢切除术。
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.
5
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
6
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.根治性子宫切除术联合放化疗与单纯根治性子宫切除术治疗局部晚期宫颈癌的疗效比较
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD010260. doi: 10.1002/14651858.CD010260.pub3.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
Surgery for women with apical vaginal prolapse.阴道顶端脱垂女性的手术治疗。
Cochrane Database Syst Rev. 2016 Oct 1;10(10):CD012376. doi: 10.1002/14651858.CD012376.
9
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
10
Association between endometriosis and type and age of menopause: a pooled analysis of 279 948 women from five cohort studies.子宫内膜异位症与绝经类型及年龄之间的关联:来自五项队列研究的279948名女性的汇总分析
Hum Reprod. 2025 Jun 1;40(6):1210-1219. doi: 10.1093/humrep/deaf068.

本文引用的文献

1
Validity of self-reported hysterectomy and oophorectomy in a population-based cohort: The HUNT study.基于人群的队列研究:自我报告的子宫切除术和卵巢切除术的有效性。
BJOG. 2024 Oct;131(11):1555-1562. doi: 10.1111/1471-0528.17859. Epub 2024 May 27.
2
Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.基于韩国健康保险数据库的队列研究:绝经后激素治疗与乳腺癌风险的关联。
Eur J Endocrinol. 2024 Jan 3;190(1):1-11. doi: 10.1093/ejendo/lvad168.
3
Hysterectomy, bilateral oophorectomy, and breast cancer risk in a racially diverse prospective cohort study.
子宫切除术、双侧卵巢切除术与乳腺癌风险:一项种族多样化的前瞻性队列研究。
J Natl Cancer Inst. 2023 Jun 8;115(6):662-670. doi: 10.1093/jnci/djad038.
4
Sex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study.性激素与乳腺癌风险:两样本孟德尔随机化研究。
Breast Cancer Res. 2022 Oct 8;24(1):66. doi: 10.1186/s13058-022-01553-9.
5
Menopausal Hormone Therapy Formulation and Breast Cancer Risk.绝经激素治疗方案与乳腺癌风险。
Obstet Gynecol. 2022 Jun 1;139(6):1103-1110. doi: 10.1097/AOG.0000000000004723. Epub 2022 May 3.
6
The surgical menopause.手术绝经。
Best Pract Res Clin Obstet Gynaecol. 2022 May;81:111-118. doi: 10.1016/j.bpobgyn.2022.03.001. Epub 2022 Mar 9.
7
Oral Contraceptive Use and Breast Cancer Risk Assessment: A Systematic Review and Meta-Analysis of Case-Control Studies, 2009-2020.口服避孕药的使用与乳腺癌风险评估:2009 - 2020年病例对照研究的系统评价与荟萃分析
Cancers (Basel). 2021 Nov 12;13(22):5654. doi: 10.3390/cancers13225654.
8
Menopausal Hormone Therapy and the Role of Estrogen.绝经期激素治疗与雌激素的作用
Clin Obstet Gynecol. 2021 Dec 1;64(4):757-771. doi: 10.1097/GRF.0000000000000648.
9
Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.子宫平滑肌瘤症状的管理:ACOG 实践公告,第 228 号。
Obstet Gynecol. 2021 Jun 1;137(6):e100-e115. doi: 10.1097/AOG.0000000000004401.
10
Premature or early bilateral oophorectomy: a 2021 update.过早或早期双侧卵巢切除术:2021 年更新。
Climacteric. 2021 Oct;24(5):466-473. doi: 10.1080/13697137.2021.1893686. Epub 2021 Mar 15.